Clinical Trials Browser

Phase 1 × 14-O-phosphonooxymethyltriptolide disodium salt × 30 days × Clear all

NCT05166616 2026-03-05

Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer

Phase 1 Active not recruiting

Lung Neoplasms